POP Act
- Bill Number
- H.R. 5433
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Commerce
- Status
- Introduced
- Latest Action
- 2025-09-17: Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-12-09T22:13:42Z
AI-Generated Summary
Purpose of the Legislation
The "Patients Over Profit Act" (H.R. 5433), also known as the "POP Act," seeks to prevent conflicts of interest in the health care system by prohibiting the same entity from owning or controlling both health insurance companies and certain Medicare-participating health care providers. The goal is to prioritize patient care over financial profits by reducing incentives for insurers to influence provider decisions.
Key Provisions
- Prohibition on Common Ownership: It is illegal for any person (including individuals or companies) to directly or indirectly own, operate, or control both:
- A "health insurance issuer" (a company that sells health insurance plans, as defined under federal law).
- An "applicable provider" (any entity paid under Medicare Part B for doctor services or under Medicare Advantage plans, excluding hospitals, critical access hospitals, rural emergency hospitals, suppliers of durable medical equipment like wheelchairs, or pharmacies) or a "management services organization" (MSO, an entity that provides administrative support to providers via a contract).
- Divestment Requirements: Entities in violation must sell off (divest) either the provider/MSO or the insurance issuer:
- Within 2 years if ownership existed before the law's enactment.
- Within 1 year if acquired after enactment.
- Enforcement and Penalties:
- The Inspector General of the Department of Health and Human Services (HHS), the Department of Justice's (DOJ) Antitrust Division, the Federal Trade Commission (FTC), or a state attorney general can file civil lawsuits in federal court.
- Courts can order violators to stop the practice, divest assets, and return (disgorge) any profits earned from health services during the violation period.
- Disgorged funds go into a special FTC-managed account to support community health needs, without limiting individuals' rights to sue separately.
- FTC Oversight:
- Divestments must be reported to the FTC and DOJ for antitrust review (under the Clayton Act, which prevents mergers that harm competition, bypassing usual size thresholds).
- Review periods pause the divestment timeline.
- FTC and DOJ must assess impacts on competition, financial stability, and public interest for each divestment and any follow-on acquisitions.
- Rulemaking: The FTC must create rules to implement the law, without weakening its requirements.
- Medicare-Specific Rules (Amendments to the Social Security Act):
- For Medicare Advantage (private plans offering Medicare benefits) starting January 1, 2026: HHS cannot contract with or pay organizations violating the ownership ban; organizations must certify compliance and provide related information.
- Violations make claims for payment "false claims" under federal fraud laws (False Claims Act).
- Medicare Part D (prescription drug plans) incorporates the same prohibition.
- Definitions and Scope:
- Key terms include "applicable provider," "health insurance issuer," "management services agreement" (contracts for admin support), "MSO," and "person" (broadly defined under antitrust law to include businesses).
- The law does not limit other existing enforcement powers of HHS, DOJ, FTC, or states.
Significant Changes to Existing Law
- Introduces a new nationwide ban on common ownership between health insurers and non-hospital Medicare providers, which was not previously prohibited under federal antitrust or health care laws like the Sherman Act or Social Security Act.
- Adds specific divestment timelines and disgorgement remedies tailored to health care, expanding beyond general antitrust tools.
- Integrates enforcement directly into Medicare Advantage and Part D programs, making non-compliance a barrier to federal payments and triggering fraud penalties—changes not present in prior Medicare rules.
- Requires mandatory reporting and enhanced reviews for divestments, strengthening FTC/DOJ oversight without raising typical merger review thresholds.
Potential Impacts
- Government Agencies: Increases workload for HHS (via Centers for Medicare & Medicaid Services for certifications and payments), FTC (rulemaking, fund management, reviews), and DOJ (antitrust actions); state attorneys general gain new civil enforcement tools, potentially leading to more coordinated federal-state efforts.
- Citizens: Medicare beneficiaries (about 65 million older or disabled Americans) may see reduced insurer influence on care decisions, potentially improving access and quality; however, divestments could temporarily disrupt insurance options or provider networks. Disgorged funds could support local health services, benefiting underserved communities.
- International Relations: No direct impacts, as the law focuses on domestic U.S. health care and insurance markets.
Main Stakeholders Affected
- Health Insurance Issuers: Companies like UnitedHealth or Humana may need to divest provider arms (e.g., physician practices they own), affecting business models.
- Health Care Providers: Non-hospital Medicare providers (e.g., doctor groups, clinics) and MSOs cannot share owners with insurers, potentially limiting consolidation but preserving independence.
- Patients and Consumers: Medicare enrollees benefit from reduced profit-driven care decisions; broader health plan holders may see indirect effects if insurers adjust nationwide.
- Government Entities: HHS, FTC, DOJ, and state attorneys general enforce and oversee compliance.
- Businesses and Investors: Owners of integrated health entities face forced sales, impacting valuations and mergers.
Notable Legal, Constitutional, or Political Implications
- Legal: Bolsters antitrust enforcement in health care by creating targeted prohibitions and remedies (e.g., disgorgement for community benefit), potentially leading to more lawsuits; integrates with existing fraud laws, making violations easier to prosecute as false claims.
- Constitutional: Divestment mandates could raise Fifth Amendment "takings" concerns (government forcing asset sales without compensation), though likely upheld as economic regulation similar to antitrust precedents; no clear free speech or due process issues.
- Political: Addresses growing concerns over corporate consolidation in health care (e.g., vertical integration where insurers buy providers), introduced by a bipartisan group but with progressive emphasis on "patients over profit"; could influence future debates on health care competition without altering broader insurance regulations like the Affordable Care Act.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (5)
Rep. Ryan, Patrick [D-NY-18], Rep. Jayapal, Pramila [D-WA-7], Rep. Ocasio-Cortez, Alexandria [D-NY-14], Rep. Khanna, Ro [D-CA-17], Rep. Balint, Becca [D-VT-At Large]
Recent Actions
- 2025-09-17: Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-09-17: Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-09-17: Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-09-17: Introduced in House
- 2025-09-17: Introduced in House
Bill Versions
- Patients Over Profit Act — issued 2025-09-17 — PDF (11 pages)